Corporate
About Medicago
Corporate strategy
Management team
Board of directors
Scientific advisory council
Current partnerships
Technologies
Medicago technologies
Vaccines
Influenza
Pandemic market
Why Plants?
Tobacco
Alfalfa
Why Proficia™?
Why VLPs?
VLPExpress
Patents/IP
Scientific publications
Manufacturing
Facility overview
Advantages
How does it work?
Products
Product pipeline
Pandemic flu vaccine
Recent results
Partnering opportunities
Investors
Why invest
Stock quote
Events & presentations
Financial Reports
Stockholder information
Analyst Coverage
Corporate governance
FAQs
Glossary of terms
IR contact
RSS feeds
News
News releases
Medicago in the news
Useful links
Partnerships
Current partnerships
Partnership opportunities
Investors
Why invest
Stock quote
Events & presentations
Financial Reports
Stockholder information
Analyst Coverage
Corporate governance
FAQs
Glossary of terms
IR contact
RSS feeds
Why invest
Stock quote
Events & presentations
Financial Reports
Stockholder information
Analyst Coverage
Corporate governance
FAQs
Glossary of terms
IR contact
RSS feeds
Analyst Coverage
Medicago is covered by the analyst(s) listed below
Claude Camire
Paradigm Capital
Toronto, Ontario
Tel: 416.361.9892
David Martin
Dundee Securities
Toronto, Ontario
Tel: 416.350.3477
Français
HOME
CAREERS
TERMS OF USE
CONTACT US
Powered By Q4 Web Systems
3.5.8.1201